KATELYN COLEMAN: Open Payments
NPI 1619590205 · FESTUS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$627 in 30 payments from 12 companies in 2025. Trend: 2023 $799 · 2024 $858 · 2025 $627
Food & beverage: $627
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $164 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $126 |
| Amgen Inc. | 3 | $61 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $52 |
| Novartis Pharmaceuticals Corporation | 3 | $51 |
| SCPHARMACEUTICALS INC. | 2 | $36 |
| Esperion Therapeutics, Inc. | 2 | $33 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| PFIZER INC. | 1 | $22 |
| Novo Nordisk Inc | 1 | $18 |
Products named: WATCHMAN FLX, JARDIANCE, REPATHA, LifeVest, LEQVIO, FUROSCIX, NEXLETOL, CAMZYOS.
Industry payments across MO — which companies pay providers there.
